Showing results (4961-4970 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|March 19, 2010
Concrete options and ideas for increasing value in oncology care: the view from one trenchThomas J Smith, Bruce E HillnerThe Oncologist|October 27, 2005
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group studyTheofanis Economopoulos, Sotirios Papageorgiou, Dimitra Rontogianni, et al.The Oncologist|November 10, 2009
Circulating tumor cells: evolving evidence and future challengesEfrat Dotan, Steven J Cohen, Katherine R Alpaugh, et al.The Oncologist|April 25, 2019
Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and OncologistsKah Poh Loh, Supriya G Mohile, Jennifer L Lund, et al.The Oncologist|April 19, 2019
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World PopulationLucio Crinò, Paolo Bidoli, Angelo Delmonte, et al.The Oncologist|September 27, 2018
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part SarcomaMiso Kim, Tae Min Kim, Bhumsuk Keam, et al.The Oncologist|September 28, 2018
Venous Thromboembolism in Patients with Sarcoma: A Retrospective StudyThierry Alcindor, Ali Al-Fakeeh, Krista Goulding, et al.The Oncologist|April 13, 2019
"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced CancerClaribel Simmons, Donald C McMillan, Sharon Tuck, et al.The Oncologist|October 12, 2018
Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A ReviewAlfred I Neugut, Paul Sackstein, Grace C Hillyer, et al.The Oncologist|August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath TumorsDavid R D'Adamo, Mark A Dickson, Mary L Keohan, et al.Pageof 571